ジェンマブは革新的な抗体医薬の開発に注力し患者さんの生活を改善することに力を尽くしています
私たちはextranotordinary な未来を共に築くことを使命とし革新的な抗体製品の開発や人々を感動させる抗体医薬品でがんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え治療の未来を切り拓いています
ジェンマブは思いやりがあり率直で患者さんに貢献したいという強い思いを持った人たちがともに働き科学に基づく変化をもたらします大胆さと高潔性を持って行動し新しい未来をつくることを目指すこと がこの使命を果たすために不可欠だと信じています
私たちは大きな志を掲げ楽しくそして思いやりの心を忘れずに日々意義のある仕事に取り組んでいます私たちは個々のユニークな貢献を受け入れそれらを原動力として患者ケアパートナーご家族そして社員のニーズを満たす革新的なソリューションを生み出し育み維持するグローバルな企業文化の構築に努めています
私たちの想いに共鳴し自分らしく活躍できそうだと感じたらぜひ一緒に働きましょう
Overview:
The Sr. Manager Japan Clinical Trial Manager (JCTM) is accountable for delivery of Japan and/or selected deliverables within a trial (e.g. manage and oversee vendor deliverables collaborate with functions to set up activities e.g. eCRF IRT eRT support site activation and recruitment support data review/cleaning activities support PI/ICF development). Scope of responsibilities depending on number of patients/sites/size of trial. The Sr. Manager JCTM is accountable for the end-to-end delivery of a single clinical trial from strategy outline through to CSR by leading cross-functional trial specific Clinical Trial Team (CTT) to deliver clinical trials including managing the trial budget if assigned to a trial as Global Clinical Trial Manager (GCTM). As Sr. Manager JCTM the employee represents Japan Development Operations (JDO) in one or more Japan Compound Teams (J-CoT) and contributes to the compound development strategy in Japan.
Responsibilities/tasks as CTM
Trial Planning and Oversight
Set target timeline target number of patients and required number of sites in Japan together with GCTM JCoT members CRO and other related stakeholders
Review Task Orders with CROs for Japan
Involve in optimizing site costs in Japan as needed
Develop operational plans manuals and charters for the trial
Review protocol and protocol amendments
Coordinate development of Trial Oversight Plan
Review Investigators Brochure (IB) from DevOps perspective
Review Clinical Trial Application (CTA) submission package
Review Regulatory Green Light (RGL) packages in accordance with QDOC-08903
Review Development Safety Update Report (DSUR)
Develop Global Master ICF
Follow up on Trial Oversight identified findings during Oversight until closure
Site Selection and Management
Drive site selection in collaboration with Start-up
Review and approve selected sites in Japan
Review/approve SSV summary
Coordinate review of CRO country-specific informed consent forms (ICFs) with internal stakeholders
Coordinate translation/back translation process of ICFs Vendor Management and Oversight
Oversee vendor management across vendors (does not include budget/change orders)
Approve key CRO staff e.g. Clinical leads or Trial specific CRA (not including CRAs part of the partnership dedicated model which is managed via Oversight Manager)
Trial Execution and Monitoring
Ensure achievement of key milestones (CTN submission FPI LPI etc.) in Japan
Conduct initial Protocol Deviation (PD) assessments and track trends
Ensure the ongoing completeness of the electronic Trial Master File (eTMF)
Keep the Trial Management Dashboard (TMD) and portfolio app in GenSense up to date
Drive the ODB review meeting
Participate in RBQM activities (as implemented going forward)
Assist in maintenance of CTT issue log in collaboration with GCTM
Collaborate or manage study escalations both internal & external
Support GCTM to Assess KPI/KQI at the trial level
Support QA in site audit activities and potentially vendor audits (supporting with trial information and collection and providing of relevant trial documents)
Conduct booster visits
Participate in inspection readiness activities as assigned
Oversee and collaborate with CTT members/vendors/assigned functional representatives on tracking and reconciliation of trial related items such as scans blood samples etc.
Responsibilities/tasks as GCTM
Trial Leadership and Management:
Lead the Clinical Trial Team (CTT)
Lead the Trial Management (TM) team
Define and manage CTT goals (together with CTT)
Review and approve protocol and amendment changes
Review Master ICF
Approve operational plans manuals and charters for the trial
Oversee vendor selection process
Initiate and ensure the accuracy and completeness of initial Work Order (WO) / Change Orders (CO)
Drive country selection process
Coordinate and respond to IEC/IRB comments
Overview of major PDs and PD trending
Approve data cleaning plans
Work closely with CPL as needed for CST/CDT
Ensure responsibility split is developed and maintained
Review and contribute to CSR as needed
Escalate issues to CPL in a timely manner
Execute operational strategy related to Drug supply
Execute regulatory submission strategy
Execute recruitment strategy
Budget and Planning:
Assist in initial development and Manage trial budget
Plan implement & ensure maintenance detailed integrated trial timelines from study outline though CSR (Gap: GCTM/CPL need a planner e.g. MS Project to show end to end project timelines and to build trust in organization)
Develop initial recruitment projections and strategy
Approve re-baseline recruitment projections in alignment with CPL
Act as counterpart for CRO PL/PM and approve CV of PL/PM
Risk management:
Conduct study risks identification with CTT & risks management activities
Oversee CTT issue log and issue resolution
Oversee CTT Action/Decision logs are maintained
Assist in preparation for & responses to audits
Ensure CAPAs are in place if applicable
Japan specific responsibilities/tasks Drug Development in Japan: Represent JDO in one or more J-CoT o Work with JCTM to ensure each study progress and milestone achievement in Japan o Ensure that departmental input/knowledge that could impact the setup and conduct of trials is proactively considered and discussed upon operationalization of the trials o Proactively provide input on the development strategy of compound as a representative of JDO
Participate in preparation for and response to PMDA Inspection as a representative of JDO
Proactively join a cross functional activity including a process development/improvement
Collaborate with critical external stakeholders (e.g. CROs vendors experts) to drive long-term objectives across projects/programs if applicable
Participate in external initiatives/task force teams such as EFPIA and JPMA and bring experience and knowledge to the relevant stakeholders if applicable
Mentor other colleagues
The Employee shall also render such other related services and duties as may be assigned from time to time by supervisor.
Competencies
Demonstrated ability to lead & collaborate with cross-functional teams to drive operational excellence
Experience in leading & managing global teams
Experience in clinical drug development & ICH-GCP/J-GCP
Experience in trial management including budget and milestone management
Experience in mentoring CTMs and CTAs
Planning and budget management skills
Outsourcing and vendor management experience
Ability to anticipate risks and issues with proactivity to offer solutions & to timely escalate issues when needed
Ability to foster a One Team spirit inclusive mindset
Confidence to challenging status-quo thinking and behavior; can work with agility and an innovative mindset
Ability to think/behave or make decisions from the perspective of Management and/or Line Manager
Ability to align with Corporate Dev Ops Trial Management and CDT goals
Excellent written and oral communication skills in both Japanese and English
Oncology experience strongly recommended
場所
ジェンマブは可能な限り柔軟な働き方を取り入れることで社員のワークライフバランスの向上に取り組んでいます
私たちのオフィスはオープンな環境の中で従業員同士がつながることを目的としていますオフィスでもリモートワークでもお互いにつながることを大切にしイノベーションを生み出します
ジェンマブについて
ジェンマブは革新的抗体医薬を通じて患者さんの生活を向上させることを目指すグローバルバイオテクノロジー企業です
25年間情熱的で革新的そして協力的なチームが次世代抗体技術プラットフォームを開発しトランスレーショナルサイエンス定量科学データサイエンスを活用することで独自のパイプラインを確立してきましたこのパイプラインには二重特異性T細胞エンゲージャーbispecific T-cell engagers抗体薬物複合体ADC次世代免疫チェックポイントモジュレーターエフェクター機能強化抗体などが含まれています
ジェンマブのビジョンは2030年までに人々を感動させる抗体医薬品でがんやその他の深刻な病に苦しむ患者さんの生活を根本的に変えることです
ジェンマブは1999年に設立されたデンマークコペンハーゲンに本社を構え北米ヨーロッパアジア太平洋地域に国際的な拠点を展開しています
ジェンマブでは候補者個人データ及びプライバシーを重要なものと認識しており個人情報の保護に関する法律その他の関係法令を遵守しています個人情報の取扱いにご同意いただいた上ご応募ください
詳細は以下リンク先よりご確認くださいJob Applicant Privacy Notice ()
Required Experience:
Senior Manager
Founded in 1999, we are an international biotech company committed to improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms ... View more